University of Vermont

The University of Vermont Cancer Center

trial_pedskidn.html

Pediatric Kidney Cancer Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on pediatric kidney cancer research.

Status: Active - Recruiting
Study Title: Treatment of High Risk Renal Tumors
Purpose: This phase II trial is studying how well combination chemotherapy, radiation therapy, and/or surgery work in treating patients with high-risk kidney tumors.
ClinicalTrials.gov Identifier: NCT00335556
Primary/Site/Co Investigator: Alan C Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00335556?term=COG+AREN0321&rank=1
Institution Number: 00-327 COG AREN0321
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: Renal Tumors Classification, Biology, and Banking Study
Purpose: This laboratory study is looking at kidney tumors in young patients.
ClinicalTrials.gov Identifier: NCT00898365
Primary/Site/Co Investigator: Alan C Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00898365?term=COG+AREN03B2&rank=1
Institution Number: 00-327 COG AREN03B2
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: AREN0532: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Purpose: This phase III trial is studying vincristine, dactinomycin, and doxorubicin with or without radiation therapy or observation only to see how well they work in treating patients undergoing surgery for newly diagnosed stage I, stage II, or stage III Wilms tumor.
ClinicalTrials.gov Identifier: NCT00352534
Primary/Site/Co Investigator: Alan C Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00352534?term=COG+AREN0532&rank=1
Institution Number: 00-327 COG AREN0532
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: COG AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Purpose: This phase III trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with newly diagnosed stage III or stage IV Wilms tumor.
ClinicalTrials.gov Identifier: NCT00379340
Primary/Site/Co Investigator: Alan C Homans
Contact: Alan Homans (802) 847-2850
Information: http://clinicaltrials.gov/ct2/show/NCT00379340?term=COG+AREN0533&rank=1
Institution Number: 00-327 COG AREN0533
Protocol Research Type: Cooperative Group

Last modified December 05 2014 11:49 AM